Combined hepatocellular cholangiocarcinoma: Controversies to be addressed (Q26749446)

Europe PubMed Central

title

Combined hepatocellular cholangiocarcinoma: Controversies to be addressed (English)

0 references

0 references

An-Qiang Wang

1

0 references

Yong-Chang Zheng

2

0 references

Juan Du

3

0 references

Cheng-Pei Zhu

4

0 references

Han-Chun Huang

5

0 references

Shan-Shan Wang

6

0 references

Liang-Cai Wu

7

0 references

Xue-Shuai Wan

8

0 references

Hao-Hai Zhang

9

0 references

Ruo-Yu Miao

10

0 references

Xin-Ting Sang

11

0 references

Hai-Tao Zhao

World Journal of Gastroenterology

12

0 references

language of work or name

English

0 references

publication date

14 May 2016

0 references

published in

0 references

volume

22

0 references

issue

18

0 references

page(s)

4459-65

0 references

cites work

Research progress and prospects of markers for liver cancer stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Intraductal papillary neoplasm of the bile duct

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Clinicopathological characteristics and prognostic factors in combined hepatocellular carcinoma and cholangiocarcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Dr.VIS v2.0: an updated database of human disease-related viral integration sites in the era of high-throughput deep sequencing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Risk factors for combined hepatocellular-cholangiocarcinoma: a hospital-based case-control study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Combined hepatocellular cholangiocarcinomas; analysis of a large database

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Management of combined hepatocellular and cholangiocarcinoma.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Combined hepatocellular-cholangiocarcinoma: a case report

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Comparing combined hepatocellular-cholangiocarcinoma and cholangiocarcinoma: a clinicopathological study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Cholangiolocellular carcinoma with satellite nodules showing intermediate differentiation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Primary combined hepatocellular-cholangiocellular sarcoma: An unusual case

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Combined liver cell and bile duct carcinoma.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma.

19 June 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

Recurrence patterns of combined hepatocellular-cholangiocarcinoma on enhanced computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

A successful resection and long-term survival of a patient with intrahepatic recurrences of combined hepatocellular-cholangiocarcinoma: report of a case.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

A case of combined hepatocellular-cholangiocarcinoma with favorable response to systemic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

Long-term outcome of living-donor liver transplantation for combined hepatocellular-cholangiocarcinoma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

[A case of combined hepatocellular-cholangiocarcinoma with sarcomatous transformation and second primary colon cancer].

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4858629

The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma

28 November 2018

1 reference

12 December 2020

A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma Assessment of enhancement patterns on dynamics computed tomography before resection

1 reference

12 December 2020

Combined hepatocellular-cholangiocarcinoma. Cytologic findings in four cases

1 reference

12 December 2020

Genetic classification of combined hepatocellular-cholangiocarcinoma

1 reference

12 December 2020

Expression of ABH and Lewis blood group antigens in combined hepatocellular-cholangiocarcinoma. Possible evidence for the hepatocellular origin of combined hepatocellular-cholangiocarcinoma

1 reference

12 December 2020

Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy

1 reference

12 December 2020

[A case of sarcomatoid combined hepatocellular-cholangiocarcinoma]

1 reference

12 December 2020

Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases

1 reference

12 December 2020

Liver transplantation for combined hepatocellular cholangiocarcinoma

1 reference

12 December 2020

Combined hepatocellular-cholangiocarcinoma: a clinicopathological study

1 reference

12 December 2020

Transplanted patients with combined hepatocellular-cholangiocarcinoma: now what?

1 reference

12 December 2020

Combined hepatocellular-cholangiocarcinoma with variable sarcomatous transformation

1 reference

12 December 2020

The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan

1 reference

12 December 2020

Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study

1 reference

12 December 2020

Recurrent hepatocellular carcinoma is a problem we need to tackle

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I18.4459

7 January 2021